INVIGORATE 2

· Aldeyra Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INVIGORATE 2, covering 2024-04-18 to 2024-04-18. Get the full timeline:

Most recent: Clinical Trial Update: The INVIGORATE 2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Subjects With Seasonal Allergic Conjunctivitis [Phase 3]

See pricing